Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Some women with common hair loss may develop permanent hair loss.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

TrichoScan is a reliable method for measuring hair growth and is useful for assessing hair loss treatments.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

No cure for female pattern hair loss, but various effective treatments exist.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

SHBG may be a useful early indicator and treatment target for PCOS.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Higher iron levels in the blood are not linked to increased hair loss in women.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Edible seeds from the Cucurbitaceae family like pumpkin and watermelon seeds are nutritious and may have health benefits, but eating too much can cause side effects.

Hair loss in women may have causes other than hormones.

Modern hair transplants use small grafts for a natural look and drugs to prevent further loss, with high patient satisfaction.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.